Takayuki Ueno Selected Research

Takayuki Ueno Research Topics

Disease

69	Breast Neoplasms (Breast Cancer) 05/2024 - 08/2004
32	Neoplasms (Cancer) 05/2024 - 08/2004
6	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2020
5	Carcinoma (Carcinomatosis) 03/2016 - 10/2004
4	Disease Progression 09/2022 - 04/2010
3	Triple Negative Breast Neoplasms 01/2024 - 12/2019
3	Infarction (Infarctions) 01/2009 - 03/2006
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2008 - 06/2005
2	Lymphatic Metastasis 09/2022 - 01/2021
2	Fatigue 07/2022 - 01/2021
2	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2020 - 02/2019
2	Necrosis 03/2019 - 10/2004
2	Hemorrhage 03/2016 - 08/2014
2	Residual Neoplasm 09/2012 - 03/2012
2	Ischemia 01/2009 - 03/2006
2	Reperfusion Injury 05/2007 - 03/2006
1	Obesity 01/2023
1	COVID-19 07/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022
1	Polyuria 07/2022
1	Polydipsia 07/2022
1	Muscle Tissue Neoplasms 08/2021
1	Thrombosis (Thrombus) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Pathologic Complete Response 01/2019

Drug/Important Bio-Agent (IBA)

17	Estrogen ReceptorsIBA 12/2023 - 04/2010
12	Hormones (Hormone)IBA 05/2024 - 04/2011
10	Biomarkers (Surrogate Marker)IBA 07/2022 - 08/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 08/2004
6	Aromatase InhibitorsIBA 10/2019 - 04/2010
6	exemestane (Aromasin)FDA Link 09/2019 - 04/2011
5	human ERBB2 proteinIBA 12/2023 - 12/2017
5	Trastuzumab (Herceptin)FDA Link 09/2022 - 09/2018
4	ChromatinIBA 03/2023 - 06/2022
4	Circulating Tumor DNAIBA 05/2022 - 01/2019
4	Estrogens (Estrogen)FDA Link 08/2021 - 04/2010
4	Docetaxel (Taxotere)FDA Link 01/2020 - 06/2007
4	AnthracyclinesIBA 12/2017 - 08/2004
3	CytokinesIBA 01/2024 - 02/2005
3	ErbB Receptors (EGF Receptor)IBA 05/2022 - 12/2012
3	Proteins (Proteins, Gene)FDA Link 07/2021 - 10/2004
3	Progesterone Receptors (Progesterone Receptor)IBA 11/2018 - 06/2010
3	Keratin-18 (Keratin 18)IBA 06/2007 - 08/2004
2	ElementsIBA 03/2023 - 01/2023
2	TransposasesIBA 01/2023 - 06/2022
2	pertuzumabIBA 09/2022 - 09/2018
2	Epirubicin (Ellence)FDA LinkGeneric 01/2020 - 06/2007
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 06/2007
2	Letrozole (Femara)FDA LinkGeneric 02/2019 - 01/2018
2	Beclin-1IBA 02/2019 - 03/2016
2	Messenger RNA (mRNA)IBA 01/2015 - 03/2008
2	CollagenIBA 01/2015 - 03/2008
2	Bevacizumab (Avastin)FDA Link 03/2012 - 10/2011
2	Caveolin 1IBA 08/2011 - 05/2010
2	Taurine FDA Link 01/2009 - 05/2007
2	CaspasesIBA 06/2007 - 10/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006 - 02/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Ado-Trastuzumab EmtansineIBA 09/2022
1	4-azidobenzylcarazolol (pABC)IBA 09/2022
1	COVID-19 VaccinesIBA 07/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2022
1	Untranslated RNA (Noncoding RNA)IBA 07/2022
1	VaccinesIBA 07/2022
1	Phenobarbital (Luminal)FDA Link 06/2022
1	Tumor Biomarkers (Tumor Markers)IBA 05/2022
1	Carcinoembryonic AntigenIBA 05/2022
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	AntigensIBA 05/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	DesminIBA 08/2021
1	Androgen Receptors (Androgen Receptor)IBA 08/2021
1	Progesterone FDA LinkGeneric 08/2021
1	LipopolysaccharidesIBA 01/2021
1	LipopeptidesIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 04/2020
1	Histones (Histone)IBA 02/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	eribulin FDA Link 01/2020
1	Tamoxifen FDA LinkGeneric 10/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2019
1	Growth Factor ReceptorsIBA 11/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2017
1	Taxoids (Taxanes)IBA 12/2017

Therapy/Procedure

37	Therapeutics 05/2024 - 08/2004
16	Neoadjuvant Therapy 01/2022 - 08/2004
13	Drug Therapy (Chemotherapy) 05/2024 - 08/2004
3	Mitral Valve Annuloplasty 06/2009 - 04/2007
2	Mastectomy (Mammectomy) 12/2023 - 03/2019
2	Retreatment 09/2022 - 09/2018
2	Radiotherapy 05/2020 - 03/2012
2	Segmental Mastectomy (Lumpectomy) 05/2020 - 05/2017
2	Aftercare (After-Treatment) 10/2014 - 04/2010
1	Precision Medicine 01/2024
1	Overlapping Surgery 01/2023
1	Hepatectomy 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Simple Mastectomy 02/2020
1	Mammaplasty (Breast Reconstruction) 03/2019